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134 Comparison of bioﬁlm formation between Burkholderia
multivorans, Burkholderia cenocepacia, and Pseudomonas
aeruginosa in the presence or absence of mucin
G.G. Einarsson1, A. McDowell2, J.S. Elborn2, S.L. Martin1. 1School of Pharmacy,
Queen’s University, Belfast, United Kingdom; 2Centre for Infection & Immunity,
Queen’s University, Belfast, United Kingdom
We investigated the ability of three pathogens (Burkholderia multivorans,
Burkholderia cenocepacia, and Pseudomonas aeruginosa) involved in chronic
bacterial infections in the CF lung to form bioﬁlm in the presence of mucin.
Previously Landry et al. (2006) have shown that P. aeruginosa developed larger ag-
gregates when grown on mucin compared to when grown on glass. We investigated
the differences in bioﬁlm-biomass (BFBM) for a total of ﬁfty isolates belonging
to all three species when grown in vitro in the presence of porcine stomach mucin
Type III. Our results showed that on average bioﬁlm formation by P. aeruginosa
(n = 22) was signiﬁcantly higher than bioﬁlm formation by either B. multivorans
(n = 11) or B. cenocepacia (n = 17) (p< 0.0001). Further investigations within
members of B. cenocepacia demonstrated that members of the recA type-IIIA
(n = 6) formed on average signiﬁcantly higher BFBM than other B. cenocepacia
isolates (n = 11) (p< 0.0001). Further comparison of the average BFBM formation
for isolates belonging to the highly problematic ET-12 clonal complex (n = 4) and
isolates belonging to P. aeruginosa (n = 22) demonstrated that members of the ET-
12 clonal complex formed on average comparable BFBM as isolates belonging to
P. aeruginosa (p< 0.79).
This study demonstrates that members of P. aeruginosa form on average signiﬁ-
cantly higher BFBM compared to members belonging either to B. multivorans or
B. cenocepacia. However, members of the ET-12 clonal complex were observed
to form on average higher BFBM than other members of B. cenocepacia and
comparable BFBM production of P. aeruginosa when grown in vitro.
135 Congo Red staining of CF-related pathogens grown as bioﬁlms
in the absence or presence of mucin
G.G. Einarsson1, A. McDowell2, J.S. Elborn2, S.L. Martin1. 1School of Pharmacy,
Queen’s University, Belfast, United Kingdom; 2Centre for Infection & Immunity,
Queen’s University, Belfast, United Kingdom
We investigated the ability of three pathogens (Burkholderia multivorans (Bm),
Burkhoderia cenocepacia (Bc), and Pseudomonas aeruginosa (Pa)) involved in
bacterial infections of the CF lung to form bioﬁlm in vitro in the presence or
absence of mucin.
Previously, Harrison-Balestra et al. (2003) showed that Congo Red (CR) staining
was a useful tool to investigate Pa bioﬁlm formation of isolates recovered from
human burn wounds. Here CR staining was used to visually compare bioﬁlm
formation in the absence and presence of mucin.
Initial screening of a selection of isolates (n = 6), from all three species, showed a
signiﬁcant increase in bioﬁlm-biomass on microtitre plates, pre-coated with porcine
stomach mucin Type III (p< 0.0001), as shown by Crystal Violet staining. Three
clinically relevant isolates; Bm (C1576, Glasgow epidemic strain), Bc (J2315, ET-
12), and Pa (PAO219, Liverpool epidemic strain) were further analysed by CR
staining. In the presence of mucin, all three isolates formed larger and more compact
cellular aggregates than when grown in the absence of mucin. Without mucin,
bacterial isolates demonstrated thin, disparate formations comprised of only a few
bacteria.
This study demonstrates that mucin inﬂuences the ability of bacteria to adhere to
the surface and form bioﬁlm aggregates. The application of CR staining allows
visualisation of bioﬁlm formation. As mucin is a relevant molecule within the CF
lung environment, it’s inclusion as a substrate for bioﬁlm production may generate
more useful results than using plastic alone. The results indicate that mucin-coated
plates may be a more optimal model when investigating bioﬁlm formation of CF-
associated bacterial isolates.
136 Clonally identical Burkholderia cepacia complex (Bcc) sequence
type strain ST32 isolated from cystic ﬁbrosis (CF) patients in
French western Brittany compared to epidemiology of Bcc
strains in France using Multilocus sequence typing (MLST)
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Objectives: To study the Bcc sequence type (ST) strains involved in CF patients
in Roscoff compared to other centres in France (Brest, Saint-Brieuc, Rennes,
Nantes, Bordeaux, Lille, Nancy, Strasbourg, Clermont-Ferrand, Lyon, Marseille,
Nice, Paris). Methods: Bcc isolates were obtained from 80 CF patients between
1994 and 2008 and identiﬁed using RecA PCR-RFLP in Toulouse observatory
centre. ST analysis was assessed by MLST in Brest. Results: Among the 80 Bcc
isolates, 59 were identiﬁed B. cenocepacia, 20 B. multivorans and 1 B. stabilis.
Among the 59 B. cenocepacia, 22 were identiﬁed as ST32 strains after MLST
analysis; 15 of them were isolated in Roscoff out of 18 B. cenocepacia. ST32
strains were also isolated in Nancy (3/5) and sporadically in Bordeaux, Rennes,
Lille and Paris. Other ST strains were identiﬁed such as ST 31, 122, 159, 234, 241,
279 (with 1 or 2 strains in each ST) in the different French centres, without speciﬁc
localisation. Conclusion: We found in this study a clonally identical Bcc ST32 strain
(83%) isolated from CF patients followed in Roscoff (western Brittany). Since ST32
strain is the only one among ST strains of the IIIA genomovar group to be found in
matched clinical-environmental strains (Baldwin et al 2007), identiﬁcation of this
ST32 strain around Roscoff centre is ongoing.
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137* Burkholderia cenocepacia: nearing the end?
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Many CF patients in the UK became chronically infected with the highly trans-
missible and often fatal pulmonary pathogen, Burkholderia cenocepacia (Bc), in
the early part of the 1990s, following its transfer into the UK CF community from
visitors to North American Summer Camps in the late 1980s. However, effective
segregation and better microbiological surveillance has prevented further spread of
this epidemic. When our adult unit opened in 1993, we accepted a cohort of these
patients mainly from the paediatric sector and now report the outcome for our Bc
patients, 16 years later. All 41 (mean age 28 years [range 17 to 44], mean length of
infection 87 months [1 to 180], 21 male) were strictly segregated from those without
Bc infection. So far, 32 (78%) of these have died: 22 (69%; mean age 25 years [17
to 34], mean length of infection 64 months [1 to 144], 11 male) due to a fulminant
necrotising pneumonia (the cepacia syndrome), and the remaining 10 (31%) due to
respiratory failure caused by progressive lung damage (mean age 29 years [21 to
44], mean length of infection 68 months [10 to 135], 5 male). Of those still alive
(mean age 36 years [24 to 43], mean length of infection 163 months [72 to 180],
5 male), there has been little alteration in clinical state over the last 3 years (mean
FEV1 change −1.5% per year), suggesting they are a ‘survivor’ population. This
group includes one CF person who visited the original summer camps in 1988, and
whose clinical state remains unchanged, 21 years later. These data indicate that the
epidemic of Bc in Merseyside is coming to an end, through the inevitable increased
mortality caused by this organism coupled with the prevention of new cases by
effective strict segregation policies in both adult and paediatric sectors.
